Icosavax, Inc. Common Stock
ICVX
ICVX was delisted on the 16th of February, 2024.
66 hedge funds and large institutions have $224M invested in Icosavax, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 30 increasing their positions, 11 reducing their positions, and 5 closing their positions.
2,675% more call options, than puts
Call options by funds: $111K | Put options by funds: $4K
260% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 5
173% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 11
25% more funds holding
Funds holding: 53 → 66 (+13)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
69% less capital invested
Capital invested by funds: $716M → $224M (-$492M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$13M |
| 2 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$10.4M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$6.37M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.62M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$4.32M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
-$41.1M |
| 2 |
Janus Henderson Group
London,
|
-$19M |
| 3 |
PA
Perceptive Advisors
New York
|
-$8.29M |
| 4 |
BlackRock
New York
|
-$1.6M |
| 5 |
N
NanoDimension
Woodside,
California
|
-$884K |
ICVX Hedge Fund Activity: Q1 2022 in Review
66 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Icosavax, Inc. Common Stock (ICVX) for Q1 2022, worth a combined $224M — down 69% from $716M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new ICVX positions and 5 closed out — a net gain of 13 holders — while 30 added to existing stakes and 11 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $13M. The largest seller was Viking Global Investors, exiting entirely with an estimated $41.1M sold.
- 66 institutional investors held Icosavax, Inc. Common Stock (ICVX) as of Q1 2022, up from 53 in Q4 2021.
- Funds reported $224M of Icosavax, Inc. Common Stock stock for Q1 2022, down 69% quarter-over-quarter.
- 18 funds opened new Icosavax, Inc. Common Stock positions in Q1 2022 and 5 closed out, a net change of +13 holders.
- The largest Icosavax, Inc. Common Stock buyer in Q1 2022 was Fidelity Investments, an estimated $13M added.
- The largest Icosavax, Inc. Common Stock seller in Q1 2022 was Viking Global Investors, an estimated $41.1M sold.
Based on aggregated 13F filings for Q1 2022.